In this article, you’ll find some of the top content that was published on LCGC this week, including details on the recent merger between Waters Corporation and BD Biosciences.

Pakistan has raised objection on the design of four projects, especially regarding Ratle which is a run-on-river project ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Waters Corp. closed 29.90% below its 52-week high of $423.56, which the company reached on January 30th.

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...

Private equity work is up year-over-year, but tariffs, inflation and valuations continue to be an issue for dealmakers.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

Waters Corporation (WAT) stock downgraded at Wells Fargo based on execution risks related to its $17.5B M&A deal with a unit of Becton Dickinson (BDX). Read more here;.

BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.

New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.